Authors
Ivo Carre, PhD, is a senior business analyst at Lifescience Dynamics.
Oscar B. Lahoud, MD, is clinical associate professor at NYU School of Medicine; section chief, Hematology, NYU Langone Health in Brooklyn; and director for strategy and network operations, Hematology/Oncology, the Perlmutter Cancer Center.
Neal Bhatia, MD
Director of Clinical Dermatology
Therapeutics Clinical Research
San Diego, CA
Sam Peasah, PhD, MBA, RPh, director of high-value health care, University of Pittsburgh Medical Center
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
As Cencora Closes With OneOncology, Patton Says Terms Show “Trust”
3
Asundexian Reduces Risk of Stroke Recurrence in Phase 3 OCEANIC-STROKE Trial
4
Benefits, Tradeoffs of Medically Integrated Dispensing in Oncology Care: Katherine Tobon, PharmD, BCOP
5




